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Neurosarcoidosis occurs in approximately 5% of
patients with sarcoidosis. Most cases manifest as
cranial mononeuropathies, peripheral neuropathies
or encephalopathy. Neuroendocrine dysfunction is
more rarely seen. We present a case of hypopituitarism
as a manifestation of neurosarcoidosis.
A 64 year old male with a history of neurosarcoidosis
with associated hydrocephalous and seizures
presented with a transient left facial droop and
encephalopathy. He was hypothermic with a
temperature of 90.4F and bradycardic. Initial lab
studies showed an elevated serum sodium level of
150. CT scan of the head showed no infarct and
infectious workup was unremarkable. Of note, he
was recently weaned off mycophenolate mofetil and
was maintained on prednisone 17.5mg daily. MRI of
the brain showed dural enhancement with areas of
chronic ischemia. Further endocrine testing revealed
low levels of the following: TSH 0.12, LH<1.2, FSH
0.6, testosterone<5, ACTH <5. Water deprivation
testing was done due to persistent hypernatremia
and was diagnostic for diabetes insipidus.
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Based on his presentation, a neurosarcoidosis
flare with infiltration of the hypothalamic-pituitary
access and central dysregulation was suspected.
He was started on stress dose steroids, levothyroxine,
desmopressin and mycophenolate mofetil with
improvement of symptoms.
Neurosarcoidosis can present in a variety of ways;
including hypothalamic disturbances in about 2-8%
of patients and it is important for providers to have
a high clinical suspicion in order to identify the
serious hormonal disturbances associated with it.
Flares of neurosarcoidosis are especially common
when weaning patients off immunosuppressants,
such as in this case.
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